Floatz logo

COCONUT OIL

Cognitive Impairments, Mild

Bournemouth UniversityN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

150 Active assets in the Cognitive Impairments, Mild cohort.

Asset / SponsorPhaseRating
Ginkgo Biloba Extract
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase 4BBB
Nicotine
University of Southern California
Phase 2BBB
Rivastigmine
Singapore General Hospital
Phase 4BBB
Oxybutynin
University of Alberta
Phase 4BBB
Metformin
Fudan University
Phase 4BB

View all 50 →

Same molecule, other indications

COCONUT OIL is also rated in:

Alzheimer's DiseaseDormant
CC
Indicative ·
47 / 100
View asset →
urogenital tract malformationDormant
C
Indicative ·
38 / 100
View asset →
vaginal disorderDormant
C
Indicative ·
38 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →